1. Home
  2. SCL vs INVA Comparison

SCL vs INVA Comparison

Compare SCL & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCL
  • INVA
  • Stock Information
  • Founded
  • SCL 1932
  • INVA 1996
  • Country
  • SCL United States
  • INVA United States
  • Employees
  • SCL N/A
  • INVA N/A
  • Industry
  • SCL Package Goods/Cosmetics
  • INVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • SCL Consumer Discretionary
  • INVA Health Care
  • Exchange
  • SCL Nasdaq
  • INVA Nasdaq
  • Market Cap
  • SCL 1.1B
  • INVA 1.3B
  • IPO Year
  • SCL N/A
  • INVA 2004
  • Fundamental
  • Price
  • SCL $47.79
  • INVA $17.21
  • Analyst Decision
  • SCL
  • INVA Buy
  • Analyst Count
  • SCL 0
  • INVA 5
  • Target Price
  • SCL N/A
  • INVA $35.60
  • AVG Volume (30 Days)
  • SCL 154.5K
  • INVA 764.0K
  • Earning Date
  • SCL 10-29-2025
  • INVA 11-05-2025
  • Dividend Yield
  • SCL 3.22%
  • INVA N/A
  • EPS Growth
  • SCL 67.06
  • INVA N/A
  • EPS
  • SCL 2.54
  • INVA 0.53
  • Revenue
  • SCL $2,260,395,000.00
  • INVA $370,229,000.00
  • Revenue This Year
  • SCL $9.25
  • INVA $8.17
  • Revenue Next Year
  • SCL $7.93
  • INVA $12.06
  • P/E Ratio
  • SCL $18.82
  • INVA $32.27
  • Revenue Growth
  • SCL 2.64
  • INVA 12.02
  • 52 Week Low
  • SCL $44.23
  • INVA $16.67
  • 52 Week High
  • SCL $82.08
  • INVA $22.00
  • Technical
  • Relative Strength Index (RSI)
  • SCL 44.57
  • INVA 27.68
  • Support Level
  • SCL $47.09
  • INVA $17.55
  • Resistance Level
  • SCL $50.09
  • INVA $19.12
  • Average True Range (ATR)
  • SCL 1.19
  • INVA 0.52
  • MACD
  • SCL 0.18
  • INVA -0.21
  • Stochastic Oscillator
  • SCL 33.89
  • INVA 3.57

About SCL Stepan Company

Stepan Co manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on product type. The surfactants segment, which generates the majority of revenue, sells cleaning agents used in detergents, shampoos, body wash, fabric softeners, toothpastes, and other personal-care products. The polymers segment sells polyurethane used to manufacture rigid foam for thermal insulation, as well as phthalic anhydride used to make plastic components for the construction, automotive, and boating industries. The specialty products segment sells chemicals used in food and flavoring. The majority of Stepan's revenue comes from the United States, followed by France, Poland, the United Kingdom, Brazil, Mexico, and other countries.

About INVA Innoviva Inc.

Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.

Share on Social Networks: